METHYLENE BLUE INJECTION USP 10 MG
METHYLENE BLUE : 10 MG · DIN 02230770 · OMEGA LABORATORIES LIMITED
Health Canada status: MARKETED
What is METHYLENE BLUE INJECTION USP?
METHYLENE BLUE INJECTION USP 10 MG contains METHYLENE BLUE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02230770, held by OMEGA LABORATORIES LIMITED, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 11-Mar-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is METHYLENE BLUE INJECTION USP called?
Also recorded in Canada as: 10 ML methylene blue 5 MG/ML Injection [Provayblue] (US), 2 ML methylene blue 5 MG/ML Injection [Provayblue] (US), 1 ML methylene blue 10 MG/ML Injection (US), 10 ML methylene blue 10 MG/ML Injection (US), 10 ML methylene blue 5 MG/ML Injection (US), methylene blue 65 MG Oral Tablet (US), methylene blue 20 MG/ML Topical Solution (US), 2 ML methylene blue 5 MG/ML Injection (US), methylene blue 10 MG/ML Oral Solution (US), 2 ML methylene blue 10 MG/ML Prefilled Syringe (US), 10 ML methylene blue 5 MG/ML Prefilled Syringe (US), ACRIFLAVINE HYDROCHLORIDE, GENTIAN VIOLET, MALACHITE GREEN OXALATE, METHYLENE BLUE (US), ACRIFLAVINE HYDROCHLORIDE, METHYL ORANGE, ETHACRIDINE LACTATE, METHYLENE BLUE ANHYDROUS (US), ARTHCAL 1% METHYLENE BLUE (US), COPPER SULFATE PENTAHYDRATE, ETHACRIDINE LACTATE, METHYLENE BLUE ANHYDROUS (US).
Product details and regulatory record
| DIN | 02230770 |
|---|---|
| Brand name | METHYLENE BLUE INJECTION USP |
| Generic / active ingredient | METHYLENE BLUE : 10 MG |
| Manufacturer | OMEGA LABORATORIES LIMITED |
| Strength | 10 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | V03AB17 METHYLTHIONINIUM CHLORIDE |
| AHFS class | 84:24.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Mar-2001 |
| Original market date | 1997-06-07 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02230770 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2230770 |
| Brand name | METHYLENE BLUE INJECTION USP |
| Active ingredient / INN | METHYLENE BLUE : 10 MG |
| ATC code | V03AB17 |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V03 |
| AHFS class | 84:24.04 |
| Health Canada schedule | Ethical |
| Biosimilar biologic | No |
| Market authorization holder | OMEGA LABORATORIES LIMITED |
Which pack is which?
| Strength on the label | 10 MG |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAVENOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code V03AB17 METHYLTHIONINIUM CHLORIDE. 2 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| METHYLENE BLUE INJECTION | 10 MG | SOLUTION | PHEBRA PTY LTD | MARKETED | DIN 02487993 |
| METHYLENE BLEU LIQ 2% | 2 % | LIQUID | LABORATOIRE ATLAS INC | CANCELLED POST MARKET | DIN 00050474 |
| METHYLENE BLUE INJ 1% | 10 MG | LIQUID | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00465062 |
| METHYLENE BLUE INJ 1% USP | 1 % | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 00863610 |
| METHYLENE BLUE INJ 10MG/ML USP | 10 MG | LIQUID | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 01958674 |
| METHYLENE BLUE INJECTION USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 00816108 |
| METHYLENE BLUE INJECTION USP | 10 MG | SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02302756 |
| METHYLENE BLUE INJECTION USP | 10 MG | SOLUTION | HIKMA CANADA LIMITED | CANCELLED POST MARKET | DIN 02431548 |
| METHYLENE BLUE INJECTION, USP | 1 % | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 02137194 |
| METHYLENE BLUE INJECTION, USP | 10 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED PRE MARKET | DIN 02094665 |
Who else supplies METHYLTHIONINIUM CHLORIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHYLTHIONINIUM CHLORIDE appears in 5 registered pack listings across 3 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.